IN2014DN09963A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN09963A IN2014DN09963A IN9963DEN2014A IN2014DN09963A IN 2014DN09963 A IN2014DN09963 A IN 2014DN09963A IN 9963DEN2014 A IN9963DEN2014 A IN 9963DEN2014A IN 2014DN09963 A IN2014DN09963 A IN 2014DN09963A
- Authority
- IN
- India
- Prior art keywords
- cancer
- treatment
- relates
- soluble peptide
- krfyvvmwkk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Abstract
The present invention relates to a soluble peptide comprising the amino acids sequence: KRFYVVMWKK (SEQ ID NO: 1) or a function- conservative variant thereof for use in the treatment of cancer. The invention also relates to a pharmaceutical composition for use in the treatment of cancer comprising at least one soluble peptide according to the invention or at least one acid nucleic according to the invention or at least one expression vector according to the invention, or at least one host cell according to the invention and a pharmaceutically acceptable carrier.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12305636 | 2012-06-06 | ||
PCT/EP2013/061727 WO2013182650A1 (en) | 2012-06-06 | 2013-06-06 | Method and pharmaceutical composition for use in the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN09963A true IN2014DN09963A (en) | 2015-08-14 |
Family
ID=48669879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN9963DEN2014 IN2014DN09963A (en) | 2012-06-06 | 2013-06-06 |
Country Status (6)
Country | Link |
---|---|
US (4) | US9198949B2 (en) |
EP (2) | EP2858660B1 (en) |
JP (2) | JP2015520178A (en) |
CN (1) | CN104519898A (en) |
IN (1) | IN2014DN09963A (en) |
WO (1) | WO2013182650A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11285169B2 (en) * | 2013-03-13 | 2022-03-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for modulating chemotherapeutic cytotoxicity |
CA3023802A1 (en) | 2016-05-10 | 2017-11-16 | Sorbonne Universite | Agents that activate cd47 and their use in the treatment of inflammation |
EP3243522A1 (en) * | 2016-05-10 | 2017-11-15 | Université Pierre et Marie Curie (Paris 6) | Agonist agents of cd47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death |
US11759496B2 (en) * | 2016-05-10 | 2023-09-19 | Philippe Karoyan | Compounds and pharmaceutical use thereof in the treatment of cancer |
CN107703109B (en) * | 2016-08-08 | 2021-01-15 | 华东理工大学 | Two-dimensional molybdenum sulfide polypeptide composite material and application thereof in targeting CD47 cancer marker |
EP3650036A1 (en) | 2018-11-06 | 2020-05-13 | Sorbonne Universite | Synthetic peptides inducing immunogenic cell death |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005183A1 (en) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
WO1991018982A1 (en) | 1990-06-05 | 1991-12-12 | Immunex Corporation | Type ii interleukin-1 receptors |
US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
US5827498A (en) | 1994-06-07 | 1998-10-27 | Nihon Medi-Physics Co., Ltd. | Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide |
US5610271A (en) * | 1995-06-07 | 1997-03-11 | Torrey Pines Institute For Molecular Studies | Kappa receptor selective opioid peptides |
US6074849A (en) | 1995-07-19 | 2000-06-13 | Genetics Institute, Inc. | Polynucleotides encoding human CTLA-8 related proteins |
IL129910A0 (en) * | 1996-11-27 | 2000-02-29 | Boston Heart Foundation Inc | Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
US6579520B2 (en) | 1998-05-15 | 2003-06-17 | Genentech, Inc. | IL-17 related mammalian cytokine polypeptides (IL-17E) |
US6569645B2 (en) | 1999-05-14 | 2003-05-27 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
US7223731B2 (en) * | 2000-05-26 | 2007-05-29 | Beth Israel Deaconess Medical Center, Inc. | Thrombospondin-1 type 1 repeat polypeptides |
WO2006089218A2 (en) * | 2005-02-17 | 2006-08-24 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for modulating angiogenesis |
JP2009013142A (en) | 2007-07-09 | 2009-01-22 | Kyoto Univ | Mesoporous silica for sustained release |
JP5661988B2 (en) | 2008-02-26 | 2015-01-28 | 株式会社ペプタイドドア | Muscarinic receptor activators and peptides |
-
2013
- 2013-06-06 WO PCT/EP2013/061727 patent/WO2013182650A1/en active Application Filing
- 2013-06-06 EP EP13730146.1A patent/EP2858660B1/en not_active Not-in-force
- 2013-06-06 CN CN201380029870.5A patent/CN104519898A/en active Pending
- 2013-06-06 JP JP2015515526A patent/JP2015520178A/en active Pending
- 2013-06-06 US US14/406,091 patent/US9198949B2/en active Active
- 2013-06-06 IN IN9963DEN2014 patent/IN2014DN09963A/en unknown
- 2013-06-06 EP EP18192533.0A patent/EP3434276A1/en active Pending
-
2015
- 2015-10-05 US US14/874,657 patent/US20160039908A1/en not_active Abandoned
-
2017
- 2017-08-28 US US15/687,692 patent/US20170362302A1/en not_active Abandoned
- 2017-11-22 JP JP2017224767A patent/JP2018057394A/en active Pending
-
2018
- 2018-10-16 US US16/161,931 patent/US10759843B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2013182650A1 (en) | 2013-12-12 |
US9198949B2 (en) | 2015-12-01 |
US20190135898A1 (en) | 2019-05-09 |
CN104519898A (en) | 2015-04-15 |
US20170362302A1 (en) | 2017-12-21 |
EP3434276A1 (en) | 2019-01-30 |
US20150126456A1 (en) | 2015-05-07 |
US20160039908A1 (en) | 2016-02-11 |
US10759843B2 (en) | 2020-09-01 |
JP2015520178A (en) | 2015-07-16 |
JP2018057394A (en) | 2018-04-12 |
EP2858660B1 (en) | 2018-09-05 |
EP2858660A1 (en) | 2015-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX360208B (en) | Pharmaceutical composition for treatment and/or prevention of cancer. | |
MX363136B (en) | Pharmaceutical composition for treatment and/or prevention of cancer. | |
MX360211B (en) | Pharmaceutical composition for treatment and/or prevention of cancer. | |
IN2014DN09963A (en) | ||
MX2012008999A (en) | Pharmaceutical composition for treatment and/or prevention of cancer. | |
MX2012008998A (en) | Pharmaceutical composition for treatment and/or prevention of cancer. | |
MX342291B (en) | Pharmaceutical composition for treatment and/or prevention of cancer. | |
MX340016B (en) | Pharmaceutical composition for treatment and/or prevention of cancer. | |
NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
BR112014019901A8 (en) | RECOMBINANT FACTOR VIII PROTEINS | |
NZ601818A (en) | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers | |
EA033399B1 (en) | Glucagon analogues with increased solubility and/or stability and use thereof | |
MX353067B (en) | Compositions of glp-1 peptides and preparation thereof. | |
WO2017009843A3 (en) | Compositions, articles of manufacture and methods for treating cancer | |
NZ629843A (en) | Identification of channelrhodopsin-2 (chop2) mutations and methods of use | |
WO2016004906A3 (en) | Tumor vascular disrupting agent polypeptide, gene, expression vector, and use thereof | |
NZ708990A (en) | Method for activating helper t cell | |
SG10201407944TA (en) | Imp-3 oligopeptides and vaccines including the same | |
UA100127C2 (en) | Peptide cdh3 and drug containing it | |
RU2015112625A (en) | Peptide, peptide use for the treatment of cardiovascular diseases, nucleotide sequence, expression vector, host cell, pharmaceutical composition | |
NZ609916A (en) | Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof | |
MX2011008763A (en) | Foxm1 peptides and vaccines containing the same. | |
EA033437B9 (en) | Fc GAMMA RECEPTOR IIB AND USE THEREOF FOR TREATING OR PREVENTING INFLAMMATORY AND/OR AUTOIMMUNE DISEASES | |
NZ609474A (en) | Fviii peptides for immune tolerance induction and immunodiagnostics | |
NZ603442A (en) | Treatment of proliferative diseases |